Search: onr:"swepub:oai:DiVA.org:liu-187484" >
Vaginal progesteron...
-
Stadelmann, CarolineGothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi,Institute of Clinical Sciences, Department of Obstetrics and Gynecology
(author)
Vaginal progesterone as luteal phase support in natural cycle frozen-thawed embryo transfer (ProFET) : protocol for a multicentre, open-label, randomised controlled trial
- Article/chapterEnglish2022
Publisher, publication year, extent ...
-
2022-07-08
-
BMJ Publishing Group,2022
-
electronicrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:liu-187484
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-187484URI
-
https://doi.org/10.1136/bmjopen-2022-062400DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:150168856URI
-
https://gup.ub.gu.se/publication/317424URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Funding Agencies|Swedish government; ALF [ALFGBG-965526, ALFGBG-720291]; Ferring Pharmaceuticals [SU 2020-05958]; Sahlgrenska University Hospitals Research Foundation; Gothenburg Medical Society; Hjalmar Svensson foundation; county councils
-
Introduction Vaginal progesterone supplementation is frequently given to patients receiving frozen embryo transfer (FET) in the natural cycle aiming to increase the chance of pregnancy and live birth. To date, only a few studies have investigated if progesterone supplementation is beneficial in these cycles and the level of evidence for progesterone supplementation is very low. Methods and analysis The ProFET trial is a multicentre, open-label, randomised controlled trial powered for this investigation, including 1800 women with regular menstrual cycles (24-35days), aged 18-43 years planned for natural cycle-FET receiving a single blastocyst for transfer. Participants are randomised (1:1:1) to either luteal phase progesterone for 3 weeks, luteal phase progesterone for 7 weeks or no luteal phase progesterone. The participating study centres consist of 12 in vitro fertilisation-clinics in Sweden and 1 in Iceland. The primary outcome is to investigate if luteal phase support (LPS) by vaginal progesterone increases the chance of a live birth per randomised patient in a natural FET cycle compared with no LPS. Ethics and dissemination The trial was approved by the Swedish Ethical Review Authority (ID 2020-06774, 2021-02822 and 2022-01502-02) and the Swedish Medical Products Agency (ID nr 5.1-2020-102613). All participants are required to provide written informed consent. The outcome of this study will be disseminated to the public through broadcasts, newspapers and presentations at scientific congresses as well as publications in international scientific journals.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Bergh, Christina,1953Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi,Institute of Clinical Sciences, Department of Obstetrics and Gynecology(Swepub:gu)xbechr
(author)
-
Brännström, Mats,1958Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi,Institute of Clinical Sciences, Department of Obstetrics and Gynecology(Swepub:gu)xbrmat
(author)
-
Olsen, Kristbjörg HeiourLivio Fertil Ctr, Iceland
(author)
-
Khatibi, AliGothenburg University,Göteborgs universitet,Karolinska Institutet,Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi,Institute of Clinical Sciences, Department of Obstetrics and Gynecology(Swepub:gu)xkhali
(author)
-
Kitlinski, MargaretaSkane Univ Hosp Malmo, Sweden
(author)
-
Liffner, SusanneLinköpings universitet,Avdelningen för barns och kvinnors hälsa,Medicinska fakulteten,Region Östergötland, Kvinnokliniken US(Swepub:liu)susli61
(author)
-
Lundborg, EvaNord IVF, Sweden
(author)
-
Rodriguez-Wallberg, Kenny A.Karolinska Univ Sjukhuset, Sweden; Karolinska Inst, Sweden
(author)
-
Strandell, Annika,1956Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi,Institute of Clinical Sciences, Department of Obstetrics and Gynecology(Swepub:gu)xsannb
(author)
-
Westlander, GöranLivio Fertil Ctr Goteborg, Sweden
(author)
-
Widlund, GabriellaUniv Hosp Orebro, Sweden; Orebro Univ, Sweden
(author)
-
Magnusson, ÅsaGothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi,Institute of Clinical Sciences, Department of Obstetrics and Gynecology(Swepub:gu)xmagsa
(author)
-
Göteborgs universitetInstitutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi
(creator_code:org_t)
Related titles
-
In:BMJ Open: BMJ Publishing Group12:72044-6055
Internet link
Find in a library
-
BMJ Open
(Search for host publication in LIBRIS)
To the university's database
- By the author/editor
-
Stadelmann, Caro ...
-
Bergh, Christina ...
-
Brännström, Mats ...
-
Olsen, Kristbjör ...
-
Khatibi, Ali
-
Kitlinski, Marga ...
-
show more...
-
Liffner, Susanne
-
Lundborg, Eva
-
Rodriguez-Wallbe ...
-
Strandell, Annik ...
-
Westlander, Göra ...
-
Widlund, Gabriel ...
-
Magnusson, Åsa
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Obstetrics Gynae ...
- Articles in the publication
-
BMJ Open
- By the university
-
Linköping University
-
Karolinska Institutet
-
University of Gothenburg